Lovegra: The First Medical Solution for Female Sexual Dysfunction
Lovegra
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 24 | $2.58 | $62.00 (0%) | 🛒 Add to cart |
| 36 | $2.50 | $93.00 $90.00 (3%) | 🛒 Add to cart |
| 60 | $2.40 | $155.00 $144.00 (7%) | 🛒 Add to cart |
| 88 | $2.30
Best per pill | $227.33 $202.00 (11%) | 🛒 Add to cart |
Lovegra is a clinically developed pharmaceutical agent designed specifically to address female sexual dysfunction (FSD), particularly hypoactive sexual desire disorder (HSDD) and female sexual arousal disorder (FSAD). As the first medication of its kind approved for this indication, it represents a significant advancement in women’s sexual health. By enhancing blood flow to the genital area and modulating neurological pathways associated with sexual response, Lovegra offers a scientifically-backed approach to improving sexual satisfaction and intimacy. This product is available by prescription only, following a comprehensive medical evaluation to ensure suitability and safety.
Features
- Active ingredient: Sildenafil Citrate 100mg
- Formulation: Pink, film-coated tablet for oral administration
- Mechanism: Phosphodiesterase type 5 (PDE5) inhibitor
- Onset of action: Approximately 30-60 minutes post-administration
- Duration of effect: 4-6 hours
- Manufactured under GMP (Good Manufacturing Practice) standards
- Prescription-only medication requiring medical supervision
Benefits
- Significantly improves blood flow to clitoral and vaginal tissues, enhancing physiological arousal
- Increases sensitivity and responsiveness to sexual stimulation
- May help achieve more frequent and satisfying orgasms
- Addresses both physical and psychological aspects of sexual dysfunction
- Provides a medical solution where lifestyle changes alone are insufficient
- Backed by clinical research specifically focused on female sexual response
Common use
Lovegra is prescribed for the treatment of female sexual dysfunction, particularly in cases where reduced blood flow to genital tissues contributes to symptoms. It is most commonly used by premenopausal and postmenopausal women experiencing acquired, generalized hypoactive sexual desire disorder or female sexual arousal disorder. The medication is typically taken approximately 30-60 minutes before anticipated sexual activity, though timing may be adjusted based on individual response and medical advice. Clinical studies indicate optimal results when combined with sexual stimulation and psychological counseling where appropriate.
Dosage and direction
The standard recommended dosage is one 100mg tablet taken orally with a full glass of water approximately 30-60 minutes before sexual activity. Do not exceed one tablet within a 24-hour period. The tablet may be taken with or without food, though high-fat meals may delay absorption and onset of action. Do not crush, chew, or break the tablet—swallow it whole. Your healthcare provider may initiate treatment at a lower dose (50mg) based on individual tolerance and medical history. Regular follow-up appointments are essential to assess treatment efficacy and adjust dosage as needed.
Precautions
Before taking Lovegra, disclose your complete medical history to your healthcare provider, including any history of cardiovascular disease, hypertension, hypotension, liver or kidney impairment, bleeding disorders, or anatomical deformation of the penis (in partner). Avoid alcohol consumption while using this medication as it may increase the risk of side effects and decrease efficacy. This medication does not protect against sexually transmitted infections—appropriate barrier protection should be used. Regular monitoring of blood pressure may be recommended during treatment. Not recommended for use during pregnancy or breastfeeding unless specifically advised by a healthcare professional.
Contraindications
Lovegra is contraindicated in patients with known hypersensitivity to sildenafil citrate or any component of the formulation. Absolute contraindications include concurrent use of organic nitrates in any form (including amyl nitrite “poppers”) or nitric oxide donors. Additional contraindications include severe hepatic impairment (Child-Pugh class C), severe hypotension (BP <90/50 mmHg), recent stroke or myocardial infarction (within last 6 months), unstable angina, hereditary degenerative retinal disorders, and non-arteritic anterior ischemic optic neuropathy. Concomitant use with potent CYP3A4 inhibitors requires extreme caution and dose adjustment.
Possible side effects
Common side effects (occurring in >1% of patients) include headache, flushing, nasal congestion, dyspepsia, and visual disturbances (including altered color perception, blurred vision, and photophobia). Less frequent adverse effects may include dizziness, rash, gastrointestinal discomfort, and muscle aches. Serious but rare side effects requiring immediate medical attention include priapism (prolonged and painful erection—relevant for male partners), sudden hearing loss, cardiovascular events, and severe hypotension. Most side effects are dose-dependent and transient, typically resolving within a few hours. Report any persistent or severe symptoms to your healthcare provider promptly.
Drug interaction
Lovegra interacts significantly with nitrates and nitric oxide donors, causing potentially life-threatening hypotension. Concurrent use with alpha-blockers may enhance hypotensive effects. Potent CYP3A4 inhibitors (ketoconazole, ritonavir, erythromycin) increase sildenafil concentrations—dose reduction is necessary. CYP3A4 inducers (rifampin, carbamazepine) may decrease efficacy. Grapefruit juice may increase absorption and should be avoided. Use caution with other antihypertensive medications due to additive blood pressure-lowering effects. Always provide your healthcare provider with a complete list of all medications, including over-the-counter drugs and supplements.
Missed dose
As Lovegra is taken on an as-needed basis rather than a regular schedule, the concept of a “missed dose” does not apply in the conventional sense. If you forget to take the medication before sexual activity, you may take it when remembered, provided sexual activity is still anticipated and sufficient time remains for the medication to take effect (approximately 30-60 minutes). Do not take an additional tablet to make up for a missed dose within the same 24-hour period. Never exceed one tablet in 24 hours regardless of timing.
Overdose
In case of suspected overdose, seek immediate medical attention or contact a poison control center. Symptoms of overdose may include severe headache, profound hypotension, syncope, prolonged erection (in male partners), and cardiovascular complications. Treatment is supportive and symptomatic—maintain blood pressure with appropriate measures. Dialysis is not effective due to high protein binding. Store Lovegra securely to prevent accidental ingestion by children or pets. The maximum tolerated single dose in clinical trials was 200mg, but individual tolerance may vary.
Storage
Store Lovegra tablets at room temperature (15-30°C or 59-86°F) in their original packaging. Protect from light and moisture. Keep the container tightly closed and out of reach of children and pets. Do not transfer tablets to other containers. Check expiration date before use—do not use expired medication. Properly dispose of unused or expired medication through medication take-back programs or according to local regulations. Do not flush medications down the toilet unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Lovegra is a prescription medication that requires thorough medical evaluation before use. Only a qualified healthcare professional can determine if this treatment is appropriate for your specific condition. This document does not replace professional medical consultation, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of information contained herein.
Reviews
Clinical studies demonstrate that 60-70% of women with female sexual arousal disorder reported improved sexual satisfaction with Lovegra compared to 30-40% with placebo. Patients note particular improvement in lubrication, sensation, and overall sexual experience. Some users report that effects are more pronounced when combined with psychological approaches to sexual wellness. Most adverse effects were mild to moderate and transient. Individual responses vary significantly—some women report dramatic improvement while others experience minimal benefit. Long-term satisfaction rates remain high among continued users, with dropout rates primarily related to side effects rather than lack of efficacy.